PubMed چکیده/رکورد

Metabolic effects of dietary edible bird's nest intake: A 12-week double-blind randomized controlled metabolomics study.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Edible bird's nest (EBN) is a traditional functional food in Asia, with reported antioxidant and metabolic regulatory properties in preclinical studies, but evidence from controlled human studies describing its metabolic effects remains limited. This study aimed to characterize the serum metabolomic response to dietary EBN supplementation in healthy adults. In a 12-week randomized, double-blind, placebo-controlled trial, 109 healthy women were randomly assigned to placebo, low-dose EBN (3.5 g/day), or high-dose EBN (7.0 g/day). Untargeted serum metabolomics was conducted at baseline and during follow-up to assess metabolic changes associated with EBN intake. EBN intake was associated with time- and dose-dependent alterations in serum metabolomic profiles, with separation from the placebo group emerging by Week 4 and further separation observed at Week 8, followed by attenuation at Week 12. The metabolic response was primarily characterized by changes in amino acid- and lipid-related metabolites, including reduced circulating branched-chain amino acids and increased levels of phosphatidylcholine (PC 18:0) and nordihydroguaiaretic acid. Pathway analysis indicated coordinated modulation of branched-chain amino acid metabolism, glycerophospholipid metabolism, and pentose phosphate pathway-related redox processes, whereas pathway-level changes in the placebo group were limited. These findings provide human-based metabolomic evidence supporting EBN as a functional food with potential dose-dependent metabolic effects. Further studies are warranted to assess these responses across populations and intake durations, and to clarify optimal intake levels and their physiological relevance.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

Branched-chain amino acidsEdible bird's nestMetabolomicsRandomized controlled trial
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Intestinal gases as markers to study the diet-gut microbiota-host metabolism axis in humans and their relationship to metabolic health.

The gut microbiota‒host metabolism axis is a critical determinant of metabolic health, yet its functional activity remains difficult to monitor in vivo. The gut microbiota ferments undigested food components such as dietary fibers and proteins, yielding various important metabolites and gases that impact human metabolism. This review synthesizes current evidence on intestinal gases, primarily hydrogen (H2), methane (CH4) and hydrogen s…

PubMed2026

The onset of hypertension in metabolic syndrome is independent of renal sympathetic innervation.

Increased sympathetic tone and hypertension are hallmarks of metabolic syndrome and contribute to chronic kidney disease. Although renal sympathetic denervation transiently lowers blood pressure, its role in the development of metabolic and renal alterations remains unclear. Here, we evaluated the contribution of renal sympathetic input to the onset and progression of high-fat diet-induced alterations. Male Wistar rats underwent bilate…

PubMed2026

Lactiplantibacillus plantarum WJL ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein diet.

Low-protein diets (LPD) are recommended in chronic kidney disease (CKD) to reduce disease progression. However, their clinical efficacy and safety are debated due to the risk of protein-energy wasting. A deeper mechanistic understanding is therefore required. Herein, the metabolic effects of LPD in both murine models and a randomized controlled trial in nondiabetic CKD patients were investigated, focusing on glucose homeostasis, plasma…

PubMed2026

Christensenella massiliensis reduces kynurenine levels and alleviates obesity and related metabolic disorders in model mice.

Next-generation probiotics derived from gut commensals show promise for metabolic disease intervention, yet effective anti-obesity strains remain limited. Here, we demonstrate that oral administration of Christensenella massiliensis markedly alleviates obesity and metabolic dysfunction in high-fat diet-induced obese mice. Treatment reduced food intake, improved glucose tolerance and insulin sensitivity, lowered blood glucose and lipid …